CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $927,000 | -94.7% | 51,600 | -91.3% | 0.14% | -88.6% |
Q3 2018 | $17,415,000 | +2.7% | 592,959 | +59.0% | 1.22% | +2.7% |
Q2 2018 | $16,960,000 | +48.7% | 372,988 | +72.7% | 1.18% | +31.3% |
Q1 2018 | $11,406,000 | -4.6% | 216,024 | +22.9% | 0.90% | +16.9% |
Q4 2017 | $11,957,000 | -32.8% | 175,842 | -18.6% | 0.77% | -33.5% |
Q3 2017 | $17,795,000 | +153.8% | 215,962 | +188.4% | 1.16% | +142.0% |
Q2 2017 | $7,011,000 | +270.2% | 74,881 | +263.5% | 0.48% | +426.4% |
Q3 2015 | $1,894,000 | – | 20,600 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |